Ayatollahi Vida, Hajiesmaeili Mohammad Reza, Behdad Shekoufeh, Gholipur Mohammad, Abbasi Hamid Reza
Associate Professor, Department of Anesthesiology, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran.
J Res Med Sci. 2011 Oct;16(10):1340-6.
Postanesthetic shivering is one of the most common complications of anesthesia. We compared the efficacy of meperidine and two low doses of ketamine with placebo to prevent postanesthetic shivering after general anesthesia.
This was a prospective, randomized double-blind placebo controlled clinical trial involving 120 ASA I-II patients aging 20-50 years, undergoing endoscopic sinus surgery with general anesthesia. Patients were randomly allocated to receive meperidine 0.4 mg/kg (Group M, n = 30), ketamine 0.3 mg/kg (Group K(1), n = 30), ketamine 0.5 mg/kg (Group K(2), n = 30), or normal saline (Group N, n = 30) 20 minutes before completion of the surgery. Tympanic temperature, blood pressure, and heart rate were measured before and immediately after induction of anesthesia, 30 minutes after induction, and before administration of the study drugs. The drugs were prepared and diluted to a volume of 2 ml and presented as coded syringes. An investigator, blinded to the groups, graded postanesthetic shivering using a four-point scale. Statistical analyses were performed using Statistical Package for Social Sciences (SPSS) Windows version 16. A p-value < 0.05 was considered statistically significant.
Patient characteristics of the four groups were similar. The number of patients with observed shivering in groups was 0, 3, 1, and 9 in Groups M, K(1), K(2) and N, respectively. The difference between groups M, K(1), and K(2) with Group N was statistically significant. However, differences between groups M and K(1), M and K(2), and K(1) and K(2) were not significant. The number of patients with a shivering score of 2 or 3 was higher in Group N compared with other groups.
Prophylactic use of low doses of intravenous ketamine (0.3 or 0.5 mg/kg) was found to be effective to prevent postanesthetic shivering. However, administration of 0.3 mg/kg ketamine lowered the rate of hallucination as compared with 0.5 mg/kg.
麻醉后寒战是麻醉最常见的并发症之一。我们比较了哌替啶和两种低剂量氯胺酮与安慰剂预防全身麻醉后寒战的效果。
这是一项前瞻性、随机双盲安慰剂对照临床试验,纳入120例年龄在20至50岁之间、接受全身麻醉下内镜鼻窦手术的美国麻醉医师协会(ASA)I-II级患者。患者在手术结束前20分钟被随机分配接受哌替啶0.4mg/kg(M组,n = 30)、氯胺酮0.3mg/kg(K(1)组,n = 30)、氯胺酮0.5mg/kg(K(2)组,n = 30)或生理盐水(N组,n = 30)。在麻醉诱导前和诱导后即刻、诱导后30分钟以及研究药物给药前测量鼓膜温度、血压和心率。药物被配制并稀释至2ml体积,以编码注射器呈现。一名对分组不知情的研究者使用四点量表对麻醉后寒战进行分级。使用社会科学统计软件包(SPSS)Windows版16进行统计分析。p值<0.05被认为具有统计学意义。
四组患者的特征相似。M组、K(1)组、K(2)组和N组中观察到寒战的患者数量分别为0、3、1和9例。M组、K(1)组和K(2)组与N组之间的差异具有统计学意义。然而,M组与K(1)组、M组与K(2)组以及K(1)组与K(2)组之间的差异不显著。与其他组相比,N组中寒战评分为2或3分的患者数量更多。
发现预防性使用低剂量静脉氯胺酮(0.3或0.5mg/kg)可有效预防麻醉后寒战。然而,与0.5mg/kg相比,给予0.3mg/kg氯胺酮降低了幻觉发生率。